mortality/aging
• mice infected with a lethal dose of HSV-1 begin to die at 3 days post infection (dpi) and all die by 6 dpi compared to wild-type mice which still show 25% survival around 7 dpi
|
immune system
• mice infected with HSV-1 show decreased induction of CCL5 in the sera
|
• mice infected with HSV-1 show decreased induction of IFN-beta in the sera
|
• mice infected with HSV-1 show decreased induction of IL-6 in the sera
|
• bone marrow-derived dendritic cells and bone-marrow-derived macrophages infected with HSV-1 exhibit decreased production of IFN-beta
|
• bone marrow-derived dendritic cells and bone-marrow-derived macrophages infected with HSV-1 exhibit decreased production of TNF
|
• mice exhibit increased susceptibility to lethal HSV-1
|
• mice infected with a lethal dose of HSV-1 begin to die at 3 days post infection (dpi) and all die by 6 dpi compared to wild-type mice which still show 25% survival around 7 dpi
|
homeostasis/metabolism
• mice infected with HSV-1 show decreased induction of CCL5 in the sera
|
• mice infected with HSV-1 show decreased induction of IFN-beta in the sera
|
• mice infected with HSV-1 show decreased induction of IL-6 in the sera
|